Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by canadapieton Aug 31, 2021 3:12am
194 Views
Post# 33786548

RE:Message for Thtx

RE:Message for Thtx Wow, man/woman?, 

Every word is truth!
You could have stated also the following: "First they are "shocked" at the low sp and lack of interest from market, but still don't BUY shares on the open market?
Mr P L said the share price "is ridicuously low"..............!!!

Also wish good luck for all the honest believers, they deserve it!

Bucknelly21:
Message for Thtx 
While I applaud the accomplishments made on the pipeline front here are issues from where I am sitting. First they are "shocked" at the low sp and lack of interest from market? Why because you have an open label trial where you have so many ways to update/let the market know how it's progressing without really giving an uncomfortable amount of information away. You don't need to tell anyone "we have cured cancer" but certainly can say more than what you have. Second if you have the attitude that you are above the average retail investor you aren't, you have burned multiple analysts, failed to correct bad forecasts and jumped on any money that is thrown your way at the expense of legacy shareholders and the atm looks to be setting it up again ( possibly). You  paid a bunch of money to assess the market for trogarzo and Brian Abrahams from Rbc picked up the phone and made a few calls and got the actual market forecast for trogarzo correct. Who is responsible for that? Three, no one has a clue what your Nash plan is, so cloudy and so unclear yet you say you are in a position of strength. Despite saying it went smoothly with both regulatory agencies while it clearly didn't. You have not been able to capture any part of this historic bull market because of you unwillingness to change your strategy in dealing with the markets. Told shareholders that change was coming on that front and the only thing you have done was hire Lsa to put on a fireside chat that was probably 90% existing shareholders. No retail engagement whatsoever even when pre clinical programs left and right get crazy evaluations with nothing but hopes in there program. If you would like I can pull up dozens. Did an awful offering where somehow made coverage worse. With analysts who don't even know you are months into a phase 1 cancer trial. Bigger payroll with a bunch of useless board members who don't buy shares and sit on options. That's just about in the last year or so. In summary the market doesn't believe or trust you and quite frankly I'm at that point as well. I'm stuck with my position at the point and I can easily accept that. But what's hard to accept is pretending you don't know why. Frankly I hope that the future is out of whoevers hands that makes the decisions about what to say and what not to and that the results are so good that your inability to create value for shareholders is out of your hands completely. Thats the only way this ends with everyone being happy because it's aparent that's it not Thtx's forte. Sorry if this is harsh and it's not meant to single any one person out but it's the truth. I've said my peace and I'm going to sit back and watch for a while 

good luck to all the people here who are much smarter than myself and have dedicated a lot of time and effort to teach the whys and how's to people like myself 
<< Previous
Bullboard Posts
Next >>